Virtual Mind-Body Resiliency for SARDs (AAV and SLE)
Official title: Virtual Rheum: The Development of a Virtual Mind-Body Resiliency Intervention for Patients with ANCA-Associated Vasculitis and Systemic Lupus Erythematosus
Funded at Massachusetts General Hospital · NIH-11357846 · Data updated 2026-11-12
A patient-facing program will test a virtual group-based mind-body approach to help people with ANCA-associated vasculitis and lupus cope with stress and improve well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 15, 2026 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $770,399 |
| NIH project number | 1R34AT013833-01 |
| Project ID | NIH-11357846 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with ANCA-associated vasculitis or systemic lupus erythematosus.
✕Less likely to help
Individuals without access to internet-enabled devices or those who cannot participate in group sessions may not benefit.
What this research studies
This project adapts a proven mind-body program into an online group format for people living with autoimmune diseases like AAV and SLE. It focuses on teaching skills to manage stress, improve mood, and foster resilience while navigating treatment burdens and disease flares. The study will test whether delivering the program virtually is feasible and acceptable, using a pilot randomized design to gather early data. If successful, this could lead to a scalable way to support mental and physical health in SARDs.
Why it matters
Potential benefit: If successful, participants may experience reduced stress and better coping, potentially improving quality of life.
How similar studies have gone: Prior mind-body programs have shown promise in reducing distress in autoimmune conditions, but virtual adaptation for SARDs is being explored.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Hall, Daniel Lee — Massachusetts General Hospital
- Study coordinator: Hall, Daniel Lee
Related research
Other NIH-funded projects on the same topics.
-
Immunostimulatory short non-coding RNAs and lupus
A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.
-
Antiviral factors that limit HIV in people with SLE
Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.
-
Mechanistic clues about lupus from immune disorders
This grant looks at why certain immune disorders in people with genetic immune problems lead to lupus-like symptoms, by studying patients and mouse models.
-
Subjective thinking challenges in adults with lupus as they age
This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.
-
Mitochondrial targets of antibodies in lupus (SLE)
A Johns Hopkins-led study will identify which mitochondrial membrane proteins are targeted by autoantibodies in lupus patients to understand how these immune attacks fuel the disease.
-
Influenza, Hydroxychloroquine, and the Windows of Self-Peptide Presentation in Lupus
A doctor-researcher is studying how flu infection and the lupus medication hydroxychloroquine change the way the immune system shows self-parts to trigger or prevent lupus flares in kids.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.